SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-067794
Filing Date
2023-03-10
Accepted
2023-03-10 17:29:30
Documents
12
Period of Report
2023-03-10
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d475671d8k.htm   iXBRL 8-K 25555
  Complete submission text file 0001193125-23-067794.txt   154343

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mirm-20230310.xsd EX-101.SCH 2850
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mirm-20230310_lab.xml EX-101.LAB 19500
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mirm-20230310_pre.xml EX-101.PRE 12156
6 EXTRACTED XBRL INSTANCE DOCUMENT d475671d8k_htm.xml XML 3584
Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38981 | Film No.: 23724986
SIC: 2834 Pharmaceutical Preparations